1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics

Chronic Disease Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Delve Insight

All regions

data types

  • All
    • Industry Reports
1-9 of 9 reports

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2022

  • $ 2000
  • January 2022
  • 100 pages

“Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Glucagon-Like Peptide 1 Receptor Agonists pipeline ...

  • China
  • World
  • Therapy
  • Type 2 Diabetes
  • Industry analysis

Etanercept– Biosimilar Insight, 2022

  • $ 2000
  • January 2022
  • 60 pages

“Etanercept– Biosimilar 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Etanercept Biosimilars landscape. It covers the marketed and pipeline ...

  • United States
  • World
  • Monoclonal Antibody
  • Autoimmune Disease
  • Industry analysis

Lipoxygenase Inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 80 pages

“Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Lipoxygenase Inhibitor (LOX Inhibitor) pipeline ...

  • World
  • Therapy
  • Clinical Development
  • Industry analysis

Nerve growth factor inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Nerve growth factor inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Nerve growth factor inhibitors pipeline landscape. It covers ...

  • World
  • Monoclonal Antibody
  • Therapy
  • Industry analysis

Dipeptidyl peptidase 4 inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Dipeptidyl Peptidase 4 Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Dipeptidyl Peptidase 4 Inhibitors pipeline landscape. ...

  • World
  • Therapy
  • Type 2 Diabetes
  • Industry analysis

Sodium channel blockers - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Sodium Channel Blockers - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Sodium Channel Blockers pipeline landscape. It covers the pipeline ...

  • Japan
  • World
  • Therapy
  • Biopharmaceutical
  • Industry analysis

ANGPTL3 protein inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“ANGPTL3 protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in ANGPTL3 protein inhibitors pipeline landscape. It covers the ...

  • Shandong
  • World
  • Therapy
  • Cardiovascular Disease
  • Industry analysis

IgE receptor antagonists - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“IgE receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in IgE receptor antagonists pipeline landscape. It covers the pipeline ...

  • World
  • United States
  • Therapy
  • Monoclonal Antibody
  • Industry analysis

Cholesterol Absorption Inhibitor - Pipeline Insight, 2022

  • $ 1250
  • January 2022
  • 60 pages

“Cholesterol Absorption Inhibitor - Pipeline Insight, 2022” report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Cholesterol Absorption ...

  • World
  • Cholesterol
  • Therapy
  • Industry analysis



Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on